Tenaya Therapeutics, Inc. (TNYA)
0.6832
-0.01
(-1.74%)
USD |
NASDAQ |
Sep 04, 16:00
0.6832
0.00 (0.00%)
After-Hours: 20:00
Tenaya Therapeutics Cash from Investing (Quarterly) : -0.159M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.159M |
| March 31, 2026 | -0.011M |
| December 31, 2025 | -0.067M |
| September 30, 2025 | 8.86M |
| June 30, 2025 | 24.99M |
| March 31, 2025 | 22.30M |
| December 31, 2024 | 14.10M |
| September 30, 2024 | -30.10M |
| June 30, 2024 | 21.62M |
| March 31, 2024 | -4.489M |
| December 31, 2023 | -14.92M |
| September 30, 2023 | 30.49M |
| June 30, 2023 | 25.08M |
| Date | Value |
|---|---|
| March 31, 2023 | 8.061M |
| December 31, 2022 | 5.974M |
| September 30, 2022 | 31.03M |
| June 30, 2022 | 30.21M |
| March 31, 2022 | 16.43M |
| December 31, 2021 | -62.58M |
| September 30, 2021 | -168.42M |
| June 30, 2021 | -3.236M |
| March 31, 2021 | -4.323M |
| December 31, 2020 | -8.177M |
| September 30, 2020 | -0.162M |
| June 30, 2020 | -0.989M |
| March 31, 2020 | 2.318M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -141.57M |
| Arrowhead Pharmaceuticals, Inc. | 43.68M |
| Oncolytics Biotech, Inc. | 0.00 |
| Sangamo Therapeutics, Inc. | -0.013M |
| Sarepta Therapeutics, Inc. | -93.37M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.552M |
| Cash from Financing (Quarterly) | 0.909M |
| Free Cash Flow | -52.59M |
| Free Cash Flow Per Share (Quarterly) | -0.0171 |
| Free Cash Flow to Equity (Quarterly) | 2.457M |
| Free Cash Flow to Firm (Quarterly) | -3.711M |
| Free Cash Flow Yield | -39.84% |